Differences in Receipt of Immunotherapy Treatment Among Patients With Head and Neck Cancer Key Points Question Are there clinical or sociodemographic differences among older patients receiving immunotherapy for head and neck cancer (HNC)? Findings In this cohort study of 4860 patients 65 years and older with HNC, White patients had 80% increased odds of receiving immunotherapy as part of their treatment.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Amila
Contact Amila, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack